United Kingdom · Question · Written question
UIN 77442
Abiraterone
Introduced
15 September 2025
Last action
13 October 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 October 2025
Summary
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the geographic differences in the cost of abiraterone for high-risk prostate cancer patients in England.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 September 2025
Written question
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the geographic differences in the cost of abiraterone for high-risk prostate cancer patients in England.
Source: Commons
13 October 2025
Answer
The procurement of abiraterone for secondary care is currently part of NHS England’s generic wave tender structure. NHS England tenders two regions out of six at a time to encourage competition and to ensure supply chain resilience, awarding the top two c...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-09-15/77442
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1835332
- uk · wq-1835332 · source updated 13 October 2025